Alexander Madonis, MD
Hospice and Palliative Medicine · Los Angeles, CANPI 1235435074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $539 and has fallen 93.8% since, to $33 in 2023.
Across 39 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$113
- Johnson & Johnson$95
- EMD Serono, Inc.$69
- Acrotech Biopharma Inc.$58
- Amgen$46
- Ipsen Biopharmaceuticals, Inc$37
- plus $355 from 16 others
What the payments were for
- Food & beverage$774100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $113 |
| Johnson & Johnson | 4 | $95 |
| EMD Serono, Inc. | 4 | $69 |
| Acrotech Biopharma Inc. | 3 | $58 |
| Amgen | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Foundation Medicine, Inc. | 2 | $35 |
| Viiv Healthcare Company | 2 | $34 |
| Puma Biotechnology, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $25 |
| Pfizer | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| GSK | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $21 |
| Seagen Inc. | 1 | $20 |
| Sanofi | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Bayer | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$774 in reported general payments places this provider in the 85th percentile of 195 hospice and palliative medicine providers in California.
See all hospice and palliative medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 24 | $22,185 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $4,234 |
| Oxycodone Hcl | 110 | $4,157 |
| Fentanyl | 26 | $3,474 |
| Gabapentin | 26 | $1,126 |
| Methadone Hcl | 36 | $662 |
| Hydromorphone Hcl | 42 | $583 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $473 |
| Alprazolam | 23 | $463 |
| Lorazepam | 58 | $449 |
| Morphine Sulfate | 12 | $420 |
| Mirtazapine | 30 | $235 |
| Ondansetron Hcl | 19 | $147 |
| Pantoprazole Sodium | 13 | $120 |
| Sertraline Hcl | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Los Angeles
- John leLos Angeles$363
- Christine BuiLos Angeles$243
- Sharon YeeArcadia$44K
- Neil SoniFountain Valley$28K
- Marietta Abalos-GalitoSan Jose$21K
- Humayon KhanSanta Ana$7K
- Sorin BugaDuarte$5K
- Glenn CarrFresno$5K
- Steven HarrisFoster City$5K
- Christopher PhillipsMurrieta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.